Green Cross Veterinary Products Hosts ‘GCVP Night’ in Thailand, Showcasing Global Vision and IPO Roadmap
Updated: Nov 11, 2025
Accelerating Global Market Expansion through Participation in VIV Asia 2025 and Strengthened Partnerships
From left: Na Seung-sik, CEO of Green Cross Veterinary Products; Philip Huggenberger, President of Elanco Japan; Ramiro M. Cabral, Executive Vice President of Elanco International; Byung-gon Jeong, Chairman of the Korea Animal Health Products Association; and Hyun-jin Jung, Country Manager of Elanco Korea.
Green Cross Veterinary Products (CEO Na Seung-sik) announced that it successfully participated in VIV Asia 2025—Asia’s largest international livestock exhibition—held in Bangkok, Thailand, from March 12 to 14. The company operated an independent booth and hosted a large-scale networking event, ‘GCVP Night’, on the opening evening, welcoming its global partners.
The event marked GCVP’s first official declaration of its global expansion strategy, drawing attention as a strategic platform to showcase the company’s growth potential and vision ahead of its upcoming IPO.
Celebrating its 52nd anniversary, Green Cross Veterinary Products hosted its first-ever independent overseas booth and exclusive corporate reception, demonstrating a significant milestone in the company’s globalization journey. Through the event, GCVP shared its long-term global strategy and vision with partners from around the world, reaffirming its commitment to accelerating global market expansion.
During the event, Green Cross Veterinary Products reaffirmed its commitment to strengthening collaboration with partners worldwide and expressed its ambition to grow into a global leader in the veterinary pharmaceutical industry.
Since its establishment in 1973, GCVP has achieved steady growth based on over five decades of accumulated technology and manufacturing expertise.In 2024, the company recorded a 25% year-over-year increase in exports, reaching USD 4 million, and aims to achieve USD 5 million in exports in 2025.The companion animal segment has also been expanding rapidly, now accounting for approximately 45% of total sales, demonstrating GCVP’s successful diversification into new markets.
Green Cross Veterinary Products is targeting a KOSDAQ listing in October 2025, with plans to utilize the funds raised to pursue M&A opportunities and R&D investments focused on the companion animal sector.The company has also been establishing an operational model on par with global pharmaceutical firms through its Open Innovation strategy (C&D: Connect & Development), strengthened supply chain management (SCM) capabilities, and expanded OEM partnerships.
CEO Na Seung-sik of Green Cross Veterinary Products stated,
“The Korean veterinary pharmaceutical industry now stands at a turning point — one of global expansion and value redefinition.Through a successful IPO, Green Cross Veterinary Products will rise as a leading company in the industry and help elevate the overall standing of the animal health sector.”
Meanwhile, under its corporate mission “Better life with healthy animals,” GCVP continues to strengthen the link between animal welfare and human health through ESG-based management and its One Health philosophy.다.
Comments